Willem M Lijfering

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Topics

Venous Thromboembolism

Atrial Fibrillation

Anterior Cruciate Ligament Reconstruction

Trauma Patients

Top Venues

Journal of thrombosis and haemostasis : JTH

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Willem M Lijfering
"Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism": Comment. Journal of thrombosis and haemostasis : JTH 20 (7) (2022)
Carolina E Touw, Banne Nemeth, Willem M Lijfering, Raymond A van Adrichem, Line Wilsgård, Nadezhda Latysheva, Cathrine Ramberg, Rob G H H Nelissen, John-Bjarne Hansen, Suzanne C Cannegieter
Effect of lower-leg trauma and knee arthroscopy on procoagulant phospholipid-dependent activity. Research and practice in thrombosis and haemostasis 6 (4) (2022)
Cathrine Ramberg, Kristian Hindberg, Joseph S Biedermann, Suzanne C Cannegieter, Felix J van der Meer, Omri Snir, Frank W G Leebeek, Marieke J H A Kruip, John-Bjarne Hansen, Willem M Lijfering
Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial. Journal of thrombosis and haemostasis : JTH 20 (4) (2022)
Myrthe M A Toorop, Nienke van Rein, Melchior C Nierman, Helga W Vermaas, Menno V Huisman, Felix J M van der Meer, Suzanne C Cannegieter, Willem M Lijfering
Inter- and intra-individual concentrations of direct oral anticoagulants: The KIDOAC study. Journal of thrombosis and haemostasis : JTH (2021)
Myrthe M A Toorop, Qingui Chen, Marieke J H A Kruip, Felix J M van der Meer, Melchior C Nierman, Laura Faber, Lies Goede, Suzanne C Cannegieter, Willem M Lijfering
Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence? Journal of thrombosis and haemostasis : JTH (2021)
Myrthe M A Toorop, Luuk J J Scheres, Willem M Lijfering
The relationship between DOAC levels and clinical outcomes: The measures tell the tale-Response from original authors Lijfering et al. Journal of thrombosis and haemostasis : JTH 19 (4) (2021)
Eleonora Camilleri, Nienke van Rein, Felix J M van der Meer, Melchior C Nierman, Willem M Lijfering, Suzanne C Cannegieter, null null
Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis. Research and practice in thrombosis and haemostasis 5 (7) (2021)
Myrthe M A Toorop, Willem M Lijfering, Luuk J J Scheres
The relationship between DOAC levels and clinical outcomes: The measures tell the tale. Journal of thrombosis and haemostasis : JTH 18 (12) (2020)